OVA (257-264), amide

OVA (257-264), amide is the SIINFEKL epitope presented in C-terminally amidated form for stability and conformational tuning. Its sequence supports high-affinity MHC binding while allowing investigation of terminal-charge effects. Researchers employ it to compare epitope behavior with free-acid counterparts. The peptide aids refined modeling of OVA peptide presentation.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: O05012

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C45H74N10O13
M.W/Mr.
962.2
Sequence
SIINFEKL-NH2
Length
8

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Epitope Mapping ServicesPeptide Synthesis ServicesPeptide Nucleic Acids SynthesisPeptide Analysis ServicesPeptide Modification ServicesCustom Conjugation ServicecGMP Peptide ServicePeptide CDMO
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers